ARCHIVES

Senate Committee Adds $100 Million for Cancer, Earmarks Extra Positions for NCI, Backs New Construction

This article is from The Cancer Letter archive.

Vol. 01 No. 38 | September 19, 1975

Download PDF Visit The Full Archive

Related Articles

Grant Review: NIH Names Members To New Clinical Oncology Review Panel

February 26, 1999

NCI Advisors Ok Study of Cancer In Farmers; Commit $6.6 Million to Five Year Contracts

April 3, 1992

NCI Advisory Group, Other Cancer Meetings

February 24, 1989

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

April 13, 1984